Koh Furugaki
3PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Nov 17, 2024
Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer.Takaaki Fujimura, Koh Furugaki, Hayato Mizuta
|Oct 06, 2024
Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK-inhibitor-induced tolerant persister cells in ALK-fusion-positive lung cancer.Koh Furugaki, Takaaki Fujimura, Narumi Sakaguchi
|Oct 25, 2023
FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes.Koh Furugaki, Takaaki Fujimura, Hayato Mizuta
Pageof 1
